₹1,08,000 / 2000 shares
Issue Date
10 Sep - 12 Sep'25
Investment/lot
₹1,08,000
Price Range
₹51 - ₹54
Lot Size
2000
IPO Size
₹22.31 Cr
Listing On
17 Sep'25
Issue Price
₹54
Listed Price
₹ 54
Retail Gain/Listing Gain
--
Start date
10/09/2025
End date
12/09/2025
Allotment of bids
15/09/2025
Refund Initiation
Listing on exchange
17/09/2025
(Last updated on 12 Sep 2025 04:45 PM)
| Day | Total | QIB | Retail | NII | 
|---|---|---|---|---|
Day 1 10-Sep-2025  | 0.46x  | 1x  | 0.34x  | 0.66x  | 
Day 2 11-Sep-2025  | 0.85x  | 1x  | 0.71x  | 1.18x  | 
Day 3 12-Sep-2025  | 1.78x  | 1x  | 2.08x  | 1.61x  | 
| Category | Subscription Rate | 
|---|---|
Qualified Institutions  | 1x  | 
Non-Institutional (HNI)  | 1.61x  | 
Retail  | 2.09x  | 
Total Subscription  | 1.79x  | 
The 100% book building issue of Galaxy Medicare Ltd comprises a fresh issue and an offer for sale of up to 33,08,000 and 8,24,000 equity shares, respectively. The price band is ₹51-₹54 per share and the lot size is 2000. The IPO opens on September 10, 2025 and closes on September 12, 2025.
The listing date is on or about September 17, 2025 and the allotment date is on September 15, 2025. The credit of shares to the Demat account will take place on or about September 16, 2025, while the initiation of refund will take place on or before September 16, 2025.
Galaxy Medicare Ltd offers a range of Plaster of Paris Bandages (POP Bandages), medical tapes and bandages, other surgical dressings, and external preparations for wound care and wound management. With a portfolio of 27 registered trademarks in India under various brand names, it caters extensively to both domestic and international markets. Its products are widely accepted by the medical fraternity and are supplied all over India to Central and State Government Health Departments, Corporate Hospitals and private players.
| Detail | Information | 
|---|---|
Upper Price Band  | ₹54  | 
Fresh Issue  | Up to 33,08,000 equity shares  | 
Offer for Sale  | Up to 8,24,000 equity shares  | 
EPS in ₹ for FY 25  | 2.84  | 
| Application | Lots | Shares | Amount in INR | 
|---|---|---|---|
Individual Investors (Retail) (Min)  | 2  | 4000  | 2,16,000  | 
Individual Investors (Retail) (Max)  | 2  | 4000  | 2,16,000  | 
S-HNI (Min)  | 3  | 6000  | 3,24,000  | 
S-HNI (Max)  | 9  | 18000  | 9,72,000  | 
B-HNI (Min)  | 10  | 20000  | 10,80,000  | 
| Investor Category | Shares Offered | 
|---|---|
QIBs  | Not more than 50% of the net offer  | 
Non-institutional Investors  | Not less than 15% of the net offer  | 
Retail Individual Investors  | Not less than 35% of the net offer  | 
The global plaster bandages market size was USD 8.8 billion in 2023 and is projected to reach USD 14.9 billion by 2032, expanding at a CAGR of 5.60% during 2024–2032. The market growth is attributed to the growing demand for effective healing solutions. The Indian medical tapes and bandages market was valued at ₹2,296 crore in 2021 which is expected to reach ₹3,362 crore in 2028 at a CAGR of 5.8%.
Increasing demand for effective wound care solutions is underscoring the importance of plaster bandages. These medical products, which provide support and protection to injured body parts, are a staple in healthcare settings worldwide.
Galaxy Medicare Ltd offers a range of Plaster of Paris Bandages (POP Bandages), medical tapes and bandages, other surgical dressings, and external preparations for wound care and wound management. With a portfolio of 27 registered trademarks in India under various brand names, it caters extensively to both domestic and international markets. Its products are widely accepted by the medical fraternity and are supplied all over India to Central and State Government Health Departments, Corporate Hospitals and private players.
The company’s plaster of paris bandage (POP Bandage) and other surgical dressings offer advancements in technology and design, providing improved effectiveness and convenience compared to traditional bandages.
| Company Name | PAT (in ₹ crores) | EPS (in ₹) | NAV (in ₹ per share) | Return on Net Worth (in %) | 
|---|---|---|---|---|
Galaxy Medicare Ltd  | 3.3704  | 2.84  | 14.06  | 10.25  | 
Adeshwar Meditex Ltd  | 2.0657  | 1.43  | 27.69  | 5.17  | 
KMS Medisurgi Ltd  | 0.4398  | 1.33  | 24.50  | 5.44  | 
Anchor Investor Bidding Date
The anchor investor bidding date is September 9, 2025.
IPO Registrar and Book Running Lead Manager
Galaxy Medicare Ltd is into the manufacturing, trading and exporting of medical devices, plasters of paris bandages (POP Bandage) and other surgical dressings in India. Its business encompasses:
The revenue from operations of Galaxy Medicare Ltd grew from ₹31.2052 crores in FY 23 to ₹39.2016 crores in FY 25. Its operating EBITDA margin grew from 10.05% in FY 23 to 11.69% in FY 25. Organisational stability coupled with established reputation and customer relationships has helped the company grow over the years.
Over the years, Galaxy Medicare Ltd has established its presence in India and in international markets by offering a wide range of quality consumer products. With a portfolio of 27 registered trademarks in India under various brand names, the company caters extensively to both domestic and international markets.
Its products are widely accepted by the medical fraternity and are supplied all over India to Central and State Government Health Departments, Corporate Hospitals and private players.
| Parameter | FY25 | FY24 | FY23 | 
|---|---|---|---|
Total Income (in ₹ crores)  | 40.2682  | 36.9374  | 32.0290  | 
Profit Before Tax (in ₹ crores)  | 4.5336  | 4.7260  | 2.0028  | 
Profit/(loss) After Tax for the Year (in ₹ crores)  | 3.3704  | 3.7074  | 1.5714  | 
EBITDA (in ₹ crores)  | 4.5842  | 5.2631  | 3.1353  | 
EPS in ₹  | 2.84  | 3.12  | 1.32  | 
| Parameter | FY25 | FY24 | FY23 | 
|---|---|---|---|
Profit/(loss) After Tax for the Year (in ₹ crores)  | 3.3704  | 3.7074  | 1.5714  | 
Net Cash Flow From / (Used in) Operating Activities (in ₹ crores)  | 4.4555  | 2.7084  | 3.6527  | 
Net Cash Flow From / (Used in) Investing Activities (in ₹ crores)  | 0.3224  | (0.6537)  | (1.9137)  | 
Net Cash Flow From / (Used in) Financing Activities (in ₹ crores)  | (4.7190)  | (2.0798)  | (1.8040)  | 
Total Cash and Cash Equivalents (in ₹ crores)  | 0.1327  | 0.0439  | 0.0690  | 
1. Visit the Registrar’s Website
Visit the website of Cameo Corporate Services and click on any one of the links under IPO Status Links. Choose the Name of the Company from the dropdown. Enter your PAN number, Application number or DP Client ID. Enter Captcha and click on Submit to know the allotment status.
2. Verify on the National Stock Exchange Website
The National Stock Exchange (NSE) has an IPO Bid Verification module. You can use it to check the status of Galaxy Medicare Ltd IPO. Go to www.nseindia.com and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'.
On the NSE IPO Bid Verification page, enter:
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here. 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
Galaxy Medicare IPO will be allotted on 2025-09-15.
Galaxy Medicare will list on 2025-09-17.
₹22.31 Cr is the issue size of Galaxy Medicare IPO.
The minimum lot size is 2000 shares and the investment required is ₹108000.
The price band of Galaxy Medicare IPO is ₹51 to ₹54.
You can read more about Galaxy Medicare and its IPO from the company’s red herring prospectus (RHP) here.
Galaxy Medicare Ltd’s IPO consists of a fresh issue of up to 33,08,000 equity shares aggregating up to ₹16.74 crores and an offer for sale of up to 8,24,000 equity shares aggregating to ₹4.45 crores. The total offer size combines both components and is up to 41,32,000 equity shares aggregating to ₹22.31 crore.
The IPO will open on September 10, 2025 and will close on September 12, 2025.
Dillip Kumar Das is the chairman and MD of Galaxy Medicare Ltd.
The lot size of shares in the Galaxy Medicare Ltd IPO is 2000
You can read more about the IPO of Galaxy Medicare Ltd from the company red herring prospectus here.